001     281536
005     20251103102758.0
024 7 _ |a 10.1055/a-2486-6360
|2 doi
024 7 _ |a pmid:39824222
|2 pmid
024 7 _ |a pmc:PMC12483601
|2 pmc
024 7 _ |a 0941-3790
|2 ISSN
024 7 _ |a 0949-7013
|2 ISSN
024 7 _ |a 1439-4421
|2 ISSN
024 7 _ |a 1615-5602
|2 ISSN
037 _ _ |a DZNE-2025-01154
041 _ _ |a German
082 _ _ |a 610
100 1 _ |a Walendzik, Anke
|b 0
245 _ _ |a Patient Journey von Menschen mit Down-Syndrom und Demenz: Zugang zur und Schnittstellen in der medizinischen Versorgung – eine qualitative Analyse | Access to and Transitions within the Medical Care Process of Persons with Down Syndrome and Dementia: A Qualitative Analysis
260 _ _ |a Stuttgart [u.a.]
|c 2025
|b Thieme
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1762159957_20023
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Compared to the general population, individuals with Down syndrome carry a much higher genetic risk of developing early onset Alzheimer's dementia. This leads to unique challenges and the need for a targeted patient journey.In a qualitative interview study with medical professionals, patient organisations and formal and informal care persons, we assessed barriers within the medical care process of this patient group as well as current approaches to overcome these problems. The study is one module of a multi-method project founded by the Innovation Fund of the German Joint Commission. The results presented here focus on access to and transitions within the medical care process. 14 guided interviews were conducted by a team of moderators by video conference, recorded and transcribed. The analysis of the results was carried out as a qualitative content analysis based on the methods of Mayring.Given the varying degree of premorbid intellectual disability, difficulties recognizing dementia symptoms were reported leading to delays in initiating the diagnostic process. Limited knowledge of the special disease risk and symptom manifestation in routine medical care as well as the lack of specialized medical institutions were identified as additional hurdles. Insufficient dissemination of information about existing specialised institutions to regular physicians and caregivers was criticized. All stakeholder groups drew attention to limitations in access to occupational and speech therapy because of the inadequate number of specialized therapists. Improvements suggested by the interview partners focussed on topics such as the implementation of guidance of the patient journey to and within the medical care process by one institution, easily accessible information for patients and caregivers as well as optimised training for physicians in routine care.Barriers such as insufficient availability of specialised service providers and information deficits about the specific disease risks and symptoms of the population have also been identified in international literatur; in addition, management and coordination deficits in the fragmented German health care system represent well known additional barriers. Approaches to improve the situation can be seen, on the one hand, in improved information and training offers for caregivers and service providers, and, on the other hand, in the expansion of the range of specialized service providers, in particular the Medical Centres for Adults with Disabilities. Informed by these study results and the results of other project modules, health policy recommendations for the improvement of the patient journey of patients with Down syndrome and dementia will be developed in the last project module.
536 _ _ |a 353 - Clinical and Health Care Research (POF4-353)
|0 G:(DE-HGF)POF4-353
|c POF4-353
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
650 _ 2 |a Down Syndrome: epidemiology
|2 MeSH
650 _ 2 |a Down Syndrome: therapy
|2 MeSH
650 _ 2 |a Down Syndrome: diagnosis
|2 MeSH
650 _ 2 |a Humans
|2 MeSH
650 _ 2 |a Germany: epidemiology
|2 MeSH
650 _ 2 |a Dementia: epidemiology
|2 MeSH
650 _ 2 |a Dementia: therapy
|2 MeSH
650 _ 2 |a Dementia: diagnosis
|2 MeSH
650 _ 2 |a Health Services Accessibility: statistics & numerical data
|2 MeSH
650 _ 2 |a Female
|2 MeSH
650 _ 2 |a Male
|2 MeSH
650 _ 2 |a Middle Aged
|2 MeSH
650 _ 2 |a Adult
|2 MeSH
650 _ 2 |a Qualitative Research
|2 MeSH
650 _ 2 |a Aged
|2 MeSH
650 _ 2 |a Transition to Adult Care: statistics & numerical data
|2 MeSH
700 1 _ |a Weitzel, Milena
|b 1
700 1 _ |a Giebel, Godwin D
|b 2
700 1 _ |a Raszke, Pascal
|b 3
700 1 _ |a Wasem, Jürgen
|b 4
700 1 _ |a Levin, Johannes
|0 P:(DE-2719)2811659
|b 5
|u dzne
700 1 _ |a Wagemann, Olivia
|0 P:(DE-2719)9001249
|b 6
|u dzne
700 1 _ |a Wlasich, Elisabeth
|b 7
700 1 _ |a Nübling, Georg
|0 P:(DE-2719)9001761
|b 8
|u dzne
700 1 _ |a Pantel, Johannes
|b 9
700 1 _ |a Tesky, Valentina A
|b 10
700 1 _ |a Schall, Arthur
|b 11
700 1 _ |a Hüer, Theresa
|b 12
773 _ _ |a 10.1055/a-2486-6360
|g Vol. 87, no. 10, p. 604 - 612
|0 PERI:(DE-600)2056559-8
|n 10
|p 604 - 612
|t Das Gesundheitswesen
|v 87
|y 2025
|x 0941-3790
856 4 _ |y OpenAccess
|u https://pub.dzne.de/record/281536/files/DZNE-2025-01154.pdf
856 4 _ |y OpenAccess
|x pdfa
|u https://pub.dzne.de/record/281536/files/DZNE-2025-01154.pdf?subformat=pdfa
909 C O |o oai:pub.dzne.de:281536
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 5
|6 P:(DE-2719)2811659
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 6
|6 P:(DE-2719)9001249
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 8
|6 P:(DE-2719)9001761
913 1 _ |a DE-HGF
|b Gesundheit
|l Neurodegenerative Diseases
|1 G:(DE-HGF)POF4-350
|0 G:(DE-HGF)POF4-353
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Clinical and Health Care Research
|x 0
914 1 _ |y 2025
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2024-12-28
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2024-12-28
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0130
|2 StatID
|b Social Sciences Citation Index
|d 2024-12-28
915 _ _ |a Creative Commons Attribution-NonCommercial-NoDerivs CC BY-NC-ND 4.0
|0 LIC:(DE-HGF)CCBYNCND4
|2 HGFVOC
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b GESUNDHEITSWESEN : 2022
|d 2024-12-28
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1180
|2 StatID
|b Current Contents - Social and Behavioral Sciences
|d 2024-12-28
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
|d 2024-12-28
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2024-12-28
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2024-12-28
920 1 _ |0 I:(DE-2719)1111015
|k Clinical Research (Munich)
|l Clinical Research (Munich)
|x 0
920 1 _ |0 I:(DE-2719)1111016
|k AG Levin
|l Clinical Neurodegeneration
|x 1
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a UNRESTRICTED
980 _ _ |a I:(DE-2719)1111015
980 _ _ |a I:(DE-2719)1111016
980 1 _ |a FullTexts


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21